Replies to post #3850 on Arcam AB fka AMAVF

[charlie T colton]

RE: need for expansion dictates new funding

Kommuniké från årsstämma i Arcam AB den 22 mars 2016

With Microsoft translate: Bulletin from annual general meeting of Arcam AB on 22 March 2016


Decision to authorise the Board of Directors to resolve on new share issue

The annual general meeting decided in accordance with the Board of Directors ' proposal to authorise the Board of Directors that, during the period until the next annual general meeting, on one or more occasions, to decide on a new issue of shares, private placement of convertible bonds or warrants.

The issue shall take place with or without deviation from preferential right to shareholders, and with or without provision for non-cash issue, setoff or otherwise with provisions. The total increase of the share capital pursuant to this authorization shall not exceed 2 000 000 kroons. The shares shall be issued at the current market rate.

The purpose of granting this authorization is to give the Board flexibility to finance and facilitate the accelerated expansion and development of the company, its market and products.




The Trend in share capital 2006–2014 report.

[investorhub123]

Not saying it would be Arcam that would be bought out......

I don't think Arcam will have any problems raising Capital in the markets.....

[pdb2]

I'll give my two cents which I have repetitively before.

There will be no merger. Arcam has no reason as its doing fine on its own and given the financial support of the EU bet it would not allow one in any event. Others won't buy arcam as its EBM technology right now is too limited (companies like GE are using laser more than ebm) and its easier to just buy the printers at this point and have the expansion risk to arcam. Arcam may buy smaller companies but no reason to make a sell itself to another as it makes more money by keeping its technology and production in house. Plus its obvious that Rene is really into arcam and would not like his ownership diluted.

To the extent that expansion/development financing is needed beyond cash flow, the company will simply incur debt or more probably equity financing which it authorized at the last general meeting. Since arcam does its equity issuance orderly and at market pricing, dilution and price risk will be minimized except for the overreaction of the lemmings which we have seen each time a major shareholder lightens up. We have reached new highs and we shall see how the market reacts to the ER tomorrow. I"ve given my expectations and reasoning therefore.